Page last updated: 2024-12-08

glutaryl-coenzyme a

Cross-References

ID SourceID
PubMed CID3081383
CHEBI ID15524
MeSH IDM0065527

Synonyms (21)

Synonym
ub84b82p7y ,
unii-ub84b82p7y
coenzyme a, s-(hydrogen pentanedioate)
3'-phosphoadenosine 5'-{3-[(3r)-4-{[3-({2-[(4-carboxybutanoyl)sulfanyl]ethyl}amino)-3-oxopropyl]amino}-3-hydroxy-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate}
CHEBI:15524
4-carboxybutanoyl-coenzyme a
C00527 ,
GLUTARYL-COA ,
3131-84-8
glutaryl-coenzyme a
4-carboxybutanoyl-coa
GRA ,
coenzyme a, glutaryl-
glutaryl coenzyme a lithium salt
coenzyme a, s-(hydrogen glutarate)
J-000893
LMFA07050324
(3r,5s,9r)-1-[(2r,3s,4r,5r)-5-(6-amino-9h-purin-9-yl)-4-hydroxy-3-(phosphonooxy)tetrahydrofuran-2-yl]-3,5,9-trihydroxy-8,8-dimethyl-10,14,19-trioxo-2,4,6-trioxa-18-thia-11,15-diaza-3,5-diphosphatricosan-23-oic acid 3,5-dioxide (non-preferred name)
Q3066713
5-((2-(3-((2r)-4-(((((((2r,3s,4r,5r)-5-(6-amino-9h-purin-9-yl)-4-hydroxy-3-(phosphonooxy)tetrahydrofuran-2-yl)methoxy)(hydroxy)phosphoryl)oxy)(hydroxy)phosphoryl)oxy)-2-hydroxy-3,3-dimethylbutanamido)propanamido)ethyl)thio)-5-oxopentanoic acid
5-(2-(3-(((2r)-4-((((2r,3s,4s,5r)-5-(6-aminopurin-9-yl)-4-oxidanyl-3-phosphonooxy-oxolan-2-yl)methoxy-oxidanyl-phosphoryl)oxy-oxidanyl-phosphoryl)oxy-3,3-dimethyl-2-oxidanyl-butanoyl)amino)propanoylamino)ethylsulfanyl)-5-oxidanylidene-pentanoic acid
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
mouse metaboliteAny mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
glutaryl-CoAsAny omega-carboxyacyl-CoA in which the acyl group specified is glutaryl or its substituted derivative.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (43)

TimeframeStudies, This Drug (%)All Drugs %
pre-199012 (27.91)18.7374
1990's1 (2.33)18.2507
2000's5 (11.63)29.6817
2010's17 (39.53)24.3611
2020's8 (18.60)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (6.67%)6.00%
Case Studies2 (4.44%)4.05%
Observational0 (0.00%)0.25%
Other40 (88.89%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
chemdatabank.com